In consultation: Guidance and quality standards
Showing 1 to 7 of 7
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Obsessive-compulsive disorder and body dysmorphic disorder: assessment and management | Draft scope consultation | NICE guideline | |
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer [ID6339] | Draft guidance | Technology appraisal guidance | |
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Draft scope consultation | NICE guideline | |
Polycystic ovary syndrome: assessment and management | Draft scope consultation | NICE guideline | |
Rehabilitation for chronic neurological disorders including acquired brain injury | Draft guidance consultation | NICE guideline | |
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235 | Draft guidance | Technology appraisal guidance | |
Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive, HER2-negative early breast cancer [ID6153] | Draft guidance | Technology appraisal guidance |